| 번호 | 논문제목 | 저자 | 학술지 | 게재일 |
|---|---|---|---|---|
| 1822 | CB1 Receptor Activation and Inhibition Differentially Modulate Cognitive Deficits and Neuropathology in 3xTg-AD Mice | 김진수(방사성의약품개발팀,20%) | Biomedicine & Pharmacotherapy | 2025-11-27 |
| 1821 | In Vivo Tracing and Systemic Organ Biodistribution of Dermally Exposed Nanopolystyrene | 조이시 산무게아(방사성의약품개발팀,40%), 김승연(방사성의약품개발팀,10%), 정혜주(방사성의약품개발팀,10%), 홍아름(방사성의약품개발팀,10%), 김진수(방사성의약품개발팀,30%) | Journal of Hazardous Materials | 2025-11-26 |
| 1820 | Benzalkonium chloride accumulates and causes toxicity in the heart and pancreas following the repeated inhalation exposures | 정지영(방사성의약품제조팀,13%), 최세환(방사성의약품제조팀,3%), 장재백(방사성의약품제조팀,3%), 권미혜(약물평가팀,3%), 이일중(방사성의약품제조팀,3%), 김동현(방사성의약품제조팀,10%) | Science of the Total Environment | 2025-11-24 |
| 1819 | Nanoplastics Cause an Increased Risk of Parkinson’s Disease Compared to Microplastics at Environmental Exposure Levels | 정혜주(방사성의약품개발팀,40%), 조이시 산무게아(방사성의약품개발팀,10%), 김진수(방사성의약품개발팀,30%) | Journal of Hazardous Materials Advances | 2025-11-13 |
| 1818 | Nodal Modulator Regulates Chemo- and Radioresistance in Lung Cancer via the Chk2 Pathway | 김주영(방사선반응조절연구팀,19%), 송지영(방사선의생명연구부,5%), 박종국(연구기획부,5%), 안지연(방사선반응조절연구팀,5%), 황상구(방사선반응조절연구팀,18%) | Anticancer Research | 2025-11-01 |
| 1817 | Comparative Analysis of Dynamic Conformal Arc Therapy and Volumetric-Modulated Arc Therapy in Lung Stereotactic Body Radiation Therapy: Evaluating Dosimetric Performance, Treatment Delivery Efficiency, and Plan Robustness | 장원일(방사선종양학과4,20%) | Anticancer Research | 2025-11-01 |
| 1816 | Adrenal Glands as Secondary Target Organs of Inhaled Benzalkonium Chlorides | 권미혜(약물평가팀,2%), 김동현(방사성의약품제조팀,10%), 정지영(방사성의약품제조팀,15%), 장재백(방사성의약품제조팀,3%), 이일중(방사성의약품제조팀,2%), 최세환(방사성의약품제조팀,2%) | Ecotoxicology and Environmental Safety | 2025-10-21 |
| 1815 | Combined HIF-1α blockade and CHIR99021 treatment reverses pulmonary fibrosis via modulation endothelial-to-mesenchymal transition | 남재경(방사선생체영향연구팀,30%), 이윤진(방사선생체영향연구팀,25%), 최서현(방사선영향연구부,10%), 이지용(방사선생체영향연구팀,10%), 김지희(방사선생체영향연구팀,10%), 이해준(방사선바이오소재개발팀,5%), 최규진(방사선생체영향연구팀,5%) | iScience | 2025-10-19 |
| 1814 | Cell-Cell Interations as Predictive and Prognostic Markers for Durg Responses in Cancer | 김은주(방사선생체영향연구팀,30%) | Genome Medicine | 2025-10-10 |
| 1813 | Feasibility and limitations of a postal dosimetry audit system using RPLGD for high-dose-rate brachytherapy | 권혁준(방사선종양학과,40%), 김금배(방사선치료기술표준팀,30%), 최상현(방사선치료기술표준팀,20%) | Radiation Physics and Chemistry | 2025-10-01 |
논문
혁신적 암치료를 선도하는 세계 방사선의학의 중심, 한국원자력의학원
-
- 현재 페이지의 화면이 이해하기 쉽게 구성되어 사용하기에 편리합니까?
-
- 현재 페이지에서 원하는 기능이 충분히 제공되었습니까?
-
- 사용자가 원하는 페이지를 쉽게 찾을 수 있었습니까?
평가하기